- Home
- KPTI vs WKHS Comparison
KPTI vs WKHS Comparison
Compare KPTI & WKHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPTI | WKHS |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.7M | 31.8M |
| IPO Year | 2013 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KPTI | WKHS |
|---|---|---|
| Price | $0.88 | $2.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $7.25 | $3.00 |
| AVG Volume (30 Days) | ★ 1.2M | 67.7K |
| Earning Date | 11-02-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 86.92 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $146,067,000.00 | $763,173.00 |
| Revenue This Year | N/A | $61.80 |
| Revenue Next Year | $27.98 | $67.74 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $1.20 | $0.53 |
| 52 Week High | $10.99 | $11.80 |
Technical Indicators
Market Signals| Indicator | KPTI | WKHS |
|---|---|---|
| Relative Strength Index (RSI) | 23.57 | 49.05 |
| Support Level | N/A | $2.98 |
| Resistance Level | $2.16 | $3.18 |
| Average True Range (ATR) | 0.16 | 0.13 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 0.00 | 50.69 |
Price Performance
Historical ComparisonAbout KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric vehicles, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.